| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ptc Therapeutics, Inc. (PTCT) has 18 insiders with recent SEC Form 4 filings, including 0 buys and 35 sells. PTCT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 394.1K | $27.27M | - | |
| Dir | 163.3K | $11.30M | - | |
| CFO | 90.3K | $6.25M | - | |
| Other | 80.1K | $5.55M | - | |
| VP | 79.1K | $5.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | Almstead Neil Gregory52 | Chief Technical Ops Officer | Sale+OE | 2,464 | $90.25 | $222,376.00 | -3.9% | - | - | |
| Jul 9, 2026 | Smith Mary L. | Director | Sale+OE | 15,834 | $90.00 | $1,425,060.00 | -26.6% | - | - | |
| Jul 7, 2026 | Almstead Neil Gregory52 | Chief Technical Ops Officer | Sale+OE | 46,774 | $87.52 | $4,093,481.61 | -8.2% | - | - | |
| Jul 6, 2026 | Boulding Mark Elliott55 | Exec. VP And CLO | Sale+OE | 5,079 | $85.08 | $432,117.53 | -0.6% | - | - | |
| Jun 25, 2026 | Almstead Neil Gregory52 | Chief Technical Ops Officer | Sale+OE | 26,283 | $85.78 | $2,254,463.35 | -5.7% | - | - | |
| Jun 17, 2026 | Utter Christine Marie58 | SVP, Chief Accounting Officer | Sale+OE | 19,686 | $75.56 | $1,487,474.16 | -21.9% | - | - | |
| Jun 17, 2026 | Boulding Mark Elliott55 | Exec. VP And CLO | Sale+OE | 10,462 | $78.65 | $822,867.75 | -2.4% | - | - | |
| Apr 21, 2026 | Klein Matthew B.54 | Chief Executive Officer | Sell | 2,850 | $70.91 | $202,093.50 | -0.7% | +11.2% | - | |
| Apr 6, 2026 | Boulding Mark Elliott55 | Exec. VP And CLO | Sale+OE | 2,265 | $69.45 | $157,293.27 | -1.1% | +20.9% | - | |
| Apr 2, 2026 | Golden Lee Scott | EVP &Chief Medical Officer | Sell | 829 | $67.99 | $56,363.71 | -1.0% | +20.0% | - |